A new growth-equity firm, KeyView Partners—headed up by veterans of Ernst & Young, Deloitte & Touche, and Johnson & Johnson—is set to open its doors next month in New York, with a plan to fund medical-technology startups. According to its website, the company’s goal is to “bring together capital, operational expertise, and strategic planning.”
KeyView’s CEO, David Shrier, was an entrepreneur in residence at Ernst & Young, and prior to that, he led innovation initiatives at Walt Disney, NBC Universal, and other companies. Chairman Thomas Gardner is a turnaround specialist who worked at Procter & Gamble, Simon & Schuster, and IMS Health, and was vice president of J&J’s McNeil Consumer Products Co. Vice chairman Richard Shanley spent 25 years as an audit partner at Deloitte, where he worked with a range of private and public companies.
Shrier told VentureWire that KeyView is finalizing its first investment and seeks to make as many as 10 more in the next year. The firm plans to invest in health IT, pharmaceuticals, and medical device startups. The initial pool of capital will come from the founders and high net worth individuals, Shrier told VentureWire, and the company may eventually launch a formal fund worth $250 million to $300 million.
